No. Patient Age, y FVII:C % Type of surgery rFVIIa, mg Body weight, kg ug/kg Period of substitution Bleeding
1 Male 63 1.4 nephrectomy (clear-cell renal cell carcinoma) 82 120 683 7 days Minimal
2 Female 47 0.5 cholecystectomy * 64 74 865 7 days Minimal
3 Female 49 4.6 hernioplasty of recurrent umbilical hernia 70 109 642 7 days Minimal
4 Female 70 0.1 gynecological surgery (tumor of the minor pelvis (fibroma on histology) 67 80 838 7 days Minimal
5 Male 52 3.9 TEP of the hip joint 81 97 835 10 days < 300 ml perioperatively + 640 ml drainage/48 h

Note: * laparoscopic surgery

Table 2:Characteristics of patients with FVII:C deficiency who underwent surgery managed with rFVIIa replacement therapy